SELLAS Life Sciences (SLS) Cash & Equivalents (2010 - 2026)
SELLAS Life Sciences (SLS) reported Cash & Equivalents of $100000.0 for Q1 2026, little changed year-over-year from $100000.0 in Q1 2025, and little changed on a QoQ basis from $100000.0 in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Cash & Equivalents data on file, last reported at $100000.0 in Q1 2026.
- Quarterly Cash & Equivalents changed 0.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $100000.0, down 99.28% from the prior year.
- Cash & Equivalents was little changed at $100000.0 in Q1 2026 per SLS's latest filing, from $100000.0 in the prior quarter.
- Across five years, Cash & Equivalents topped out at $44.3 million in Q3 2025 and bottomed at $100000.0 in Q1 2022.
- The 5-year median for Cash & Equivalents is $100000.0 (2022), against an average of $6.3 million.
- The widest annual swing landed in 2022, when Cash & Equivalents tumbled 99.64%; it then surged 44220.0% in 2025.
- Tracing SLS's Cash & Equivalents over 5 years: stood at $17.1 million in 2022, then slumped by 85.23% to $2.5 million in 2023, then soared by 448.85% to $13.9 million in 2024, then plunged by 99.28% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
- Per Business Quant, the three latest SLS Cash & Equivalents figures stand at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $44.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.71 Bn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 44.32 Mn |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 13.89 Mn |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 3.97 Mn |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 23.90 Mn |
| Dec 31, 2022 | 17.13 Mn |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 21.36 Mn |
| Sep 30, 2021 | 26.30 Mn |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 28.00 Mn |
| Dec 31, 2020 | 35.30 Mn |
| Sep 30, 2020 | 8.20 Mn |
| Jun 30, 2020 | 3.30 Mn |
| Mar 31, 2020 | 100,000.00 |
| Dec 31, 2019 | 100,000.00 |
| Sep 30, 2019 | 115,000.00 |
| Jun 30, 2019 | 100,000.00 |
| Mar 31, 2019 | 2.58 Mn |
| Dec 31, 2018 | 5.34 Mn |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | 8.60 Mn |
| Mar 31, 2018 | 8.61 Mn |
| Dec 31, 2017 | 12.75 Mn |
| Sep 30, 2017 | 12.90 Mn |
| Jun 30, 2017 | 13.60 Mn |
| Mar 31, 2017 | 18.10 Mn |
| Dec 31, 2016 | 6.05 Mn |
| Sep 30, 2016 | 24.51 Mn |
| Jun 30, 2016 | 19.59 Mn |
| Mar 31, 2016 | 401,000.00 |
| Dec 31, 2015 | 1.40 Mn |
| Sep 30, 2015 | 34.71 Mn |
| Jun 30, 2015 | 45.28 Mn |
| Mar 31, 2015 | 52.86 Mn |
| Dec 31, 2014 | 23.65 Mn |
| Sep 30, 2014 | 24.65 Mn |
| Jun 30, 2014 | 39.16 Mn |
| Mar 31, 2014 | 52.43 Mn |
| Dec 31, 2013 | 47.79 Mn |
| Sep 30, 2013 | 51.40 Mn |
| Jun 30, 2013 | 20.92 Mn |
| Mar 31, 2013 | 17.48 Mn |
| Dec 31, 2012 | 32.81 Mn |
| Sep 30, 2012 | 51.40 Mn |
| Jun 30, 2012 | 19.23 Mn |
| Mar 31, 2012 | 8.70 Mn |
| Dec 31, 2011 | 47.79 Mn |
| Sep 30, 2011 | 15.69 Mn |
| Jun 30, 2011 | 17.93 Mn |
| Mar 31, 2011 | 11.12 Mn |
| Dec 31, 2010 | 6.89 Mn |
| Sep 30, 2010 | 2.84 Mn |
| Jun 30, 2010 | 5.09 Mn |